Biodesix to Acquire Oncimmune Operations, Lung Cancer Test in US - 360Dx

Biodesix to Acquire Oncimmune Operations, Lung Cancer Test in US  360Dx

NEW YORK — Biodesix said today that it has signed an agreement to acquire Oncimmune's US operations and the US rights to the firm's blood-based incidental ...